SEC Form 4 · accession 0001493152-18-008816
VBI Vaccines Inc/BC · VBIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
David Evander Anderson
Officer — Chief Scientific Officer
Period of report
Jun 14, 2018
Accepted (ET)
Jun 18, 2018 · 10:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000764195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value per shareF1 | Jun 14, 2018 | M | 21,875 | — | A | 110,615 | D | |
| Common Shares, no par value per share | Jun 14, 2018 | F | 9,306 | $3.76 | D | 101,309 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs)F1,F2 | — | Jun 14, 2018 | M | 21,875 | D | — | — | Common Shares | 21,875 | 21,875 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date.
- F2The restricted stock units vest 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date.